<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font24">the </span>
   <span class="font17">.â€‰Â±â€‰. </span>
   <span class="font15">MAO-B </span>
   <span class="font14">for </span>
   <span class="font13">AChE </span>
   <span class="font13">with </span>
   <span class="font13">were </span>
   <span class="font13">{background </span>
   <span class="font12">that </span>
   <span class="font12">The </span>
   <span class="font12">Med </span>
   <span class="font12">inhibitor </span>
   <span class="font12">margin </span>
   <span class="font12">monoamine </span>
   <span class="font12">was </span>
   <span class="font12">Chem;:â€". </span>
   <span class="font12">MO, </span>
   <span class="font12">selective </span>
   <span class="font12">{border-style </span>
   <span class="font11">inhibitors </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">&amp;gt; </span>
   <span class="font11">chalcones </span>
   <span class="font11">inhibition </span>
   <span class="font11">MAO-A </span>
   <span class="font11">compounds </span>
   <span class="font11">inhibitors. </span>
   <span class="font11">(IC </span>
   <span class="font11">are </span>
   <span class="font11">inhibited </span>
   <span class="font11">reversible </span>
   <span class="font11">ring </span>
   <span class="font11">using </span>
   <span class="font11">(Figure </span>
   <span class="font11">CNS </span>
   <span class="font11">morpholine </span>
   <span class="font11">oxidase </span>
   <span class="font11">design </span>
   <span class="font11">their </span>
   <span class="font11">Bioorg </span>
   <span class="font11">chalcone </span>
   <span class="font11">used </span>
   <span class="font11">values </span>
   <span class="font11">Figure </span>
   <span class="font11">MathewB, </span>
   <span class="font11">human </span>
   <span class="font11">interactions </span>
   <span class="font11">molecular </span>
   <span class="font11">plots </span>
   <span class="font11">potent </span>
   <span class="font11">synthesis </span>
   <span class="font11">than </span>
   <span class="font11">various </span>
   <span class="font11">which </span>
   <span class="font10">BChE </span>
   <span class="font10">Chem </span>
   <span class="font10">can </span>
   <span class="font10">drugs </span>
   <span class="font10">from </span>
   <span class="font10">most </span>
   <span class="font10">potently </span>
   <span class="font10">BaekSC, </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">acetylcholinesterase </span>
   <span class="font10">activities </span>
   <span class="font10">binding </span>
   <span class="font10">enzyme </span>
   <span class="font10">have </span>
   <span class="font10">new </span>
   <span class="font10">presence </span>
   <span class="font10">px; </span>
   <span class="font10">studies </span>
   <span class="font10">{font-family </span>
   <span class="font10">.â€‰mM </span>
   <span class="font10">Alzheimer's </span>
   <span class="font10">Docking </span>
   <span class="font10">Enzyme </span>
   <span class="font10">Pharmacy, </span>
   <span class="font10">biological </span>
   <span class="font10">determined </span>
   <span class="font10">font-size </span>
   <span class="font10">inhibitory </span>
   <span class="font10">oxidase-B </span>
   <span class="font10">performed </span>
   <span class="font10">reference </span>
   <span class="font10">showed </span>
   <span class="font10">â€" </span>
   <span class="font10">.â€‰ÂµM), </span>
   <span class="font10">Chemistry </span>
   <span class="font10">Eur </span>
   <span class="font10">MAO-A, </span>
   <span class="font10">MAO-B, </span>
   <span class="font10">ROS </span>
   <span class="font10">activity </span>
   <span class="font10">addition, </span>
   <span class="font10">agents </span>
   <span class="font10">between </span>
   <span class="font10">class </span>
   <span class="font10">derivatives </span>
   <span class="font10">docking </span>
   <span class="font10">double; </span>
   <span class="font10">drug </span>
   <span class="font10">evaluation </span>
   <span class="font10">followed </span>
   <span class="font10">inhibitions </span>
   <span class="font10">more </span>
   <span class="font10">other </span>
   <span class="font10">reported </span>
   <span class="font10">respectively, </span>
   <span class="font10">respectively. </span>
   <span class="font10">secondary </span>
   <span class="font10">âˆ’. </span>
   <span class="font10">&amp;gt;. </span>
   <span class="font10">.â€‰ÂµM; </span>
   <span class="font10">AChE, </span>
   <span class="font10">Chem;:. </span>
   <span class="font10">Department </span>
   <span class="font10">Drug </span>
   <span class="font10">Inhib </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Lineweaverâ€"Burk </span>
   <span class="font10">ParambiDGT, </span>
   <span class="font10">al.Design, </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">considered </span>
   <span class="font10">disease. </span>
   <span class="font10">groups </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">inhibitors: </span>
   <span class="font10">neurodegenerative </span>
   <span class="font10">nine </span>
   <span class="font10">results </span>
   <span class="font10">score </span>
   <span class="font10">site </span>
   <span class="font10">solid; </span>
   <span class="font10">synthetic </span>
   <span class="font10">sâˆ’) </span>
   <span class="font10">targets </span>
   <span class="font10">therapeutic </span>
   <span class="font10">this </span>
   <span class="font10">treated </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Ï€â€"Ï€ </span>
   <span class="font10">(Ki </span>
   <span class="font10">(Table </span>
   <span class="font10">(an </span>
   <span class="font10">... </span>
   <span class="font10">.â€‰ÂµM). </span>
   <span class="font10">.â€‰ÂµM, </span>
   <span class="font10">AChE. </span>
   <span class="font10">Alzheimerâ€™s </span>
   <span class="font10">Amrita </span>
   <span class="font10">Analysis </span>
   <span class="font10">CNS- </span>
   <span class="font10">Inhibition </span>
   <span class="font10">MAO </span>
   <span class="font10">Research </span>
   <span class="font10">Results </span>
   <span class="font10">Table </span>
   <span class="font10">These </span>
   <span class="font10">after </span>
   <span class="font10">assay </span>
   <span class="font10">assays </span>
   <span class="font10">been </span>
   <span class="font10">bold </span>
   <span class="font10">containing </span>
   <span class="font10">courier; </span>
   <span class="font10">dual-acting </span>
   <span class="font10">em; </span>
   <span class="font10">interaction </span>
   <span class="font10">its </span>
   <span class="font10">lazabemide </span>
   <span class="font10">measured </span>
   <span class="font10">medicinal </span>
   <span class="font10">moiety </span>
   <span class="font10">novel </span>
   <span class="font10">phenyl </span>
   <span class="font10">potential </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">residue </span>
   <span class="font10">synthesis, </span>
   <span class="font10">target </span>
   <span class="font10">treatment </span>
   <span class="font10">ÂµM) </span>
   <span class="font10">â€‰min </span>
   <span class="font10">â€‰Î¼g/mL </span>
  </p>
 </body>
</html>
